Your browser doesn't support javascript.
loading
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma.
Phillips, Tycel J; Bond, David; Takiar, Radihka; Kump, Karson; Kandarpa, Malalthi; Boonstra, Philip; Mayer, Tera Lynn; Nachar, Victoria; Wilcox, Ryan A; Carty, Shannon A; Karimi, Yasmin H; Nikolovska-Coleska, Zaneta; Kaminski, Mark S; Herrera, Alex F; Maddocks, Kami; Popplewell, Leslie; Danilov, Alexey V.
Afiliación
  • Phillips TJ; Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA.
  • Bond D; Division of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Takiar R; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Kump K; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Kandarpa M; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Boonstra P; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Mayer TL; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Nachar V; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Wilcox RA; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Carty SA; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Karimi YH; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Nikolovska-Coleska Z; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Kaminski MS; Division of Hematology-Oncology, The University of Michigan Rogel Cancer Center, Ann Arbor, MI.
  • Herrera AF; Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA.
  • Maddocks K; Division of Hematology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Popplewell L; Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA.
  • Danilov AV; Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, Duarte, CA.
Blood Adv ; 7(16): 4518-4527, 2023 08 22.
Article en En | MEDLINE | ID: mdl-37013954
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células del Manto Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células del Manto Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos